Overview

Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether monosialoganglioside are effective in the prevention of neurotoxicity induced by albumin-bound paclitaxel chemotherapy in lung cancer patients, and improve the quality of life of patients.

Phase:

Phase 2

Details

Lead Sponsor:

Beijing Cancer Hospital

Collaborators:

Beijing Shijitan Hospital
Beijing Shijitan Hospital, Capital Medical University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Chinese PLA General Hospital
Peking Union Medical College Hospital
Peking University First Hospital
Peking University Third Hospital
Weifang People's Hospital
Yantai Yuhuangding Hospital

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel